微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 30.77% | -0.87% | -5.04% | 108/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 32.4% | -13.7% | -0.81% | 106/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 32.67% | -18.29% | -1.13% | 105/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 33.04% | -19.84% | 6.45% | 107/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 31.04% | -44.41% | -17.33% | 108/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 37.55% | -25.6% | -6.09% | 98/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 39.98% | -27.05% | -3.01% | 95/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 41.22% | -22.09% | -26.18% | 92/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 55.84% | 0.14% | 10.64% | 64/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 50.47% | -30.72% | -7.91% | 76/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 54.8% | -26.39% | 3.59% | 68/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 52.91% | -30.26% | -5.11% | 69/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 55.76% | -26.25% | -23.46% | 66/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 72.84% | -2.57% | -2.16% | 22/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 74.45% | -0.34% | -1.87% | 18/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 75.86% | 3.08% | 0.34% | 18/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 75.6% | -0.45% | 1.12% | 18/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 74.77% | 6.58% | 0.08% | 22/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 74.7% | 8.22% | 1.51% | 24/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 73.59% | 9.17% | -3.1% | 29/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 75.95% | 34.3% | 8.26% | 19/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 70.15% | 40.81% | 1.63% | 44/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 69.03% | 34.06% | 2.4% | 32/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 67.41% | 32.31% | 19.21% | 40/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 56.55% | 19.49% | 13.51% | 46/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 49.82% | 19.73% | -3.24% | 72/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 51.49% | 25.2% | 1.06% | 36/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 50.95% | 23.59% | 7.66% | 44/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 47.32% | 13.28% | 13.73% | 30/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 41.61% | -3.54% | 1.18% | 77/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 41.13% | -7.82% | -0.23% | 35/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 41.22% | -7.84% | -1.33% | 39/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 41.78% | -9.21% | -3.16% | 33/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 43.14% | -0.66% | -3.31% | 70/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 44.61% | 3.57% | -0.26% | 27/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 44.73% | 5.46% | -2.79% | 35/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 46.02% | 15.18% | 5.96% | 27/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 43.43% | 15.4% | 0.81% | 55/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 43.08% | 5.43% | 1.56% | 25/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 42.42% | -2.23% | 6.17% | 31/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 39.95% | -1.53% | 6.16% | 23/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |